Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B

Fig. 1

The cumulative rate of virological and clinical relapse after cessation of nucleos(t)ide analogue (NA) treatment for 240 weeks. a Frequency of patients in sustained response, virological relapse and clinical relapse at different timepoints. b The cumulative rate of virological relapse in all patients. c The cumulative rate of clinical relapse in all patients

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us